Abound Wealth Management Ark Genomic Revolution ETF (De Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Abound Wealth Management holds 2 shares of ARKG stock, worth $50. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$50% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
293Shares Held
20.9MCall Options Held
2.79MPut Options Held
6.56M-
Main Management ETF Advisors, LLC San Francisco, CA2.75MShares$69.9 Million3.23% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$57.3 Million0.0% of portfolio
-
Ubs Group Ag1.75MShares$44.4 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.54MShares$39 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.46MShares$37 Million0.0% of portfolio